Form 4: Edwards Lifesciences Executive Larry L. Wood Reports Changes in Beneficial Ownership

Larry L. Wood, Global President TAVR & Surg at Edwards Lifesciences, reports transactions involving common stock, including disposals to cover tax obligations and acquisitions through the Employee Stock Purchase Plan.

Summary

• Larry L. Wood, Global President TAVR & Surg at Edwards Lifesciences Corp, filed a Form 4 detailing changes in beneficial ownership.
• The reported transactions include the disposal of common stock to satisfy tax obligations and the acquisition of shares through the company's Employee Stock Purchase Plan.
• On May 3, 2025, 396 shares of common stock were disposed of at a price of $75.65.
• On May 4, 2025, 410 shares of common stock were disposed of at a price of $75.65.
• Following the reported transactions, Wood directly owns 197,657.3913 shares of common stock.
• Wood also indirectly owns 148.1703 shares of common stock through a 401(k) plan.

Sentiment

Score: 6

Explanation: The sentiment is neutral as the filing reflects routine transactions related to tax obligations and employee stock purchase plans. There is no indication of unusual or concerning activity.

Positives

• The report includes quarterly acquisition of shares under the Issuer's Employee Stock Purchase Plan.

Industry Context

Form 4 filings are a routine part of executive compensation and provide transparency into the trading activities of company insiders. These filings are closely watched by investors to gauge sentiment and potential future actions by key personnel.

Comparison to Industry Standards

• Executive stock transactions are common across publicly traded companies, and the specifics (such as the number of shares, transaction price, and reasons for the transaction) vary widely based on individual circumstances and company policies.
• Companies like Medtronic, Abbott, and Boston Scientific also have executives who regularly file Form 4s, reflecting similar transactions related to stock options, restricted stock units, and employee stock purchase plans.
• The scale of these transactions is generally proportional to the executive's compensation package and the company's overall size and market capitalization.

Stakeholder Impact

• The transactions are unlikely to have a significant impact on stakeholders as they are routine and related to executive compensation and tax obligations.

Key Dates

Keywords

Form 4, Beneficial Ownership, Edwards Lifesciences, Larry L. Wood, TAVR, Stock Disposal, Employee Stock Purchase Plan, Common Stock, Executive Compensation